Physician profile
Chloe Walker
NPI 1851961221
$1,640.46
in general payments reported to CMS, 2019-2025
15 companies · $224 in 2025
The $224 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $344 · 2024: $1,073 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,541 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,541.46 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $510.91 | 2023-2025 | Rinvoq, Skyrizi |
| Regeneron Healthcare Solutions, INC. | $332.45 | 2023-2025 | Dupixent |
| Lilly USA, LLC | $172.12 | 2024-2025 | Taltz, Ebglyss, Olumiant |
| Genzyme Corporation | $169.50 | 2023-2024 | |
| Janssen Biotech, INC. | $137.22 | 2024 | Tremfya |
| Incyte Corporation | $77.54 | 2024 | Opzelura |
| Pfizer INC. | $45.65 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $36.09 | 2024 | Sotyktu |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $34.11 | 2024 | Cabtreo |
| Sun Pharmaceutical Industries INC. | $29.15 | 2024 | |
| Kyowa Kirin, INC. | $25.57 | 2025 | |
| Dermavant Sciences, INC. | $22.61 | 2024 | Vtama |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.58 | 2023 | Spevigo |
| Journey Medical Corporation | $17.00 | 2023 | |
| Biofrontera INC. | $12.96 | 2024 | Ameluz, Xepi, Bf-Rhodoled |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chloe Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.